Dorsey & Whitney Trust CO LLC Acquires 190 Shares of MetLife, Inc. (NYSE:MET)

Dorsey & Whitney Trust CO LLC grew its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 3.1% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 6,295 shares of the financial services provider’s stock after buying an additional 190 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in MetLife were worth $515,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of MET. Swedbank AB boosted its holdings in shares of MetLife by 5.3% during the 3rd quarter. Swedbank AB now owns 1,970,163 shares of the financial services provider’s stock valued at $162,499,000 after buying an additional 99,328 shares in the last quarter. Principal Financial Group Inc. boosted its stake in MetLife by 2.9% in the 3rd quarter. Principal Financial Group Inc. now owns 670,565 shares of the financial services provider’s stock worth $55,308,000 after purchasing an additional 18,788 shares in the last quarter. SpiderRock Advisors LLC boosted its stake in MetLife by 4.6% in the 3rd quarter. SpiderRock Advisors LLC now owns 13,757 shares of the financial services provider’s stock worth $1,135,000 after purchasing an additional 603 shares in the last quarter. Verdence Capital Advisors LLC boosted its stake in MetLife by 71.2% in the 3rd quarter. Verdence Capital Advisors LLC now owns 9,652 shares of the financial services provider’s stock worth $796,000 after purchasing an additional 4,013 shares in the last quarter. Finally, Assetmark Inc. boosted its stake in MetLife by 2.6% in the 3rd quarter. Assetmark Inc. now owns 97,989 shares of the financial services provider’s stock worth $8,082,000 after purchasing an additional 2,499 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

Shares of NYSE:MET opened at $79.11 on Tuesday. The firm’s 50 day moving average price is $83.68 and its 200-day moving average price is $82.38. MetLife, Inc. has a twelve month low of $67.30 and a twelve month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a market capitalization of $53.89 billion, a PE ratio of 13.25, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Equities research analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.76%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio (DPR) is presently 36.52%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on MET. Cowen reiterated a “buy” rating on shares of MetLife in a research note on Friday. JPMorgan Chase & Co. upped their price target on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. BMO Capital Markets assumed coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target on the stock. Finally, Morgan Stanley upped their target price on shares of MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $94.58.

Check Out Our Latest Stock Report on MET

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.